Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The capsular polysaccharide of Neisseria meningitidis serogroup W is a key virulence factor that enables the bacterium to evade the host immune response. It is composed of repeating units containing sialic acid residues linked to galactose (α-D-Gal-(1→4)-α-Neu5Ac-(2→6)-α-D-Glc). This polysaccharide is a target for vaccines designed to prevent invasive meningococcal disease.
Antibody-mediated opsonization and complement activation following vaccination with polysaccharide conjugates.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis Capsular Polysaccharide Serogroup W (Serogroup W CPS).